Blackstone and Goldman Sachs are looking to increase their investment presence in Asia, the companies confirmed.
In a fourth-quarter conference call last week, Blackstone—the world’s largest alternative asset manager—confirmed that it has amassed $11 billion to acquire companies in Asia in its second private-equity fund for the continent.
It raised $6.4 billion and will receive $4.6 billion from Blackstone global funds.
Despite swelling inflationary risks and geopolitical concerns, the company has been expanding its footprint in the region. Its first private-equity fund was concentrated in India, while the second endeavor will situate Blackstone’s investments across Asia-Pacific.
Blackstone confirmed that it’s negotiating three deals in Australia, India, and Japan. It’s also working on a potential agreement with a Chinese consumer firm and a South Korean business. The Wall Street titan also has real estate investment vehicles in the “pipeline.”
Over the past year, governments in the region, particularly the regime in China, have clamped down on a broad array of sectors, particularly technology. But the firm says it’s unconcerned by these actions.
“As the year unfolds, we’ll see very attractive opportunities,” said Amit Dixit, the Asia head of private equity.
“Government-related issues play a little role in our decision making.”
The New York-based asset manager has an objective of managing $1 trillion by 2026. After a record $155 billion in the October-to-December period, the firm is inching closer to the goal, and ahead of schedule.
Goldman Sachs Banking on China
Meanwhile, Goldman Sachs analysts have turned slightly bearish on the Chinese economy.
In a note last month, the financial institution warned that China could choose to stay shut for the rest of the year and possibly into the second quarter of 2023.
Since the fall, Beijing has adopted a zero-COVID strategy as part of efforts to contain outbreaks. This has involved quarantine requirements, hard lockdowns, and disruptions to production, encouraging analysts to sound the alarm about a period of stagflation.
These conditions prompted Goldman to slash its gross domestic product (GDP) forecast for 2022, warning that growing restrictions on business activity would weigh on growth potential.
This might prompt Beijing to boost liquidity and ease credit conditions by cutting its reserve requirement ratio, the amount of reserves banks are mandated to hold.
Despite these trends, Goldman is also casting its investment and wealth management shadow over the Chinese market.
After gaining approval for 100 percent ownership of its Chinese venture Goldman Sachs Gao Hua Securities Co. Ltd., the Wall Street juggernaut plans to expand its wealth and asset management products to Chinese investors.
He further revealed that the company’s private investment strategy will hone in on health care, corporate, and consumer services. There will also be a focus on environmental, social, and governance (ESG) investing.
Short-Term Loss or Long-Term Gain?
As China liberalizes its financial markets to generate more capital, a growing number of Wall Street firms are planting new roots or establishing a larger corporate presence in the world’s second-largest economy.But has this been a profitable investment in 2022?
For the first time since the early days of the U.S.–China trade dispute in 2017, mainland equities have slipped into a bear market. The CSI 300 Index of mainland stocks tumbled to a 16-month low, and the MSCI China Index slid to a 21-month low.
In addition to slumping equities, credit-market contagion is widening and government bonds are sliding.
But Wall Street juggernauts, from BlackRock to JPMorgan Chase, say they’re not too concerned. They’ve become overweight in Chinese stocks, predicted notable gains this year, or are convinced that the rout is exaggerated.
In response to the recent downturn in stocks, market observers purport that the selloff has been overdone, making many Chinese stocks attractive.
“Although risks around the Chinese growth outlook remain due to the zero-tolerance COVID-19 policies and regulatory tightening, Chinese equity markets already reflect some of those risks, offer attractive valuations and continue to be underinvested,” Goldman Sachs strategists led by Christian Mueller-Glissmann wrote in a note on Jan. 31.